Study guide
14.2 Restrictive, Arrhythmogenic, and Stress Cardiomyopathies
CCI Registered Cardiac Sonographer RCS
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: RCS Orientation and Clinical Context
1.1 RCS Identity, Exam Format, Application, and Retesting 1.2 Clinical History, Symptoms, Indications, and Risk Factors 1.3 Prior Studies, Serial Change, and Cross-Modality Context
2 Chapter 2: Orders, Safety, and Patient Preparation
2.1 Order Verification, Scope, and Protocol Selection 2.2 Sonographer Ergonomics and Staff Safety 2.3 Patient Preparation, Positioning, Consent, Infection Control, and Aftercare
3 Chapter 3: Reporting and 2-D TTE Foundations
3.1 Structured Findings, Significant Results, and Escalation 3.2 Standard 2-D TTE Windows, Views, and Acquisition Sequence 3.3 2-D Measurements, Foreshortening, Image Quality, and QA
4 Chapter 4: M-Mode and Doppler Acquisition
4.1 M-Mode Alignment, Timing, Measurements, and Pitfalls 4.2 Color Doppler Acquisition, Scale, Gain, and Jet Display 4.3 PW and CW Spectral Doppler Acquisition
5 Chapter 5: Advanced Doppler and Contrast
5.1 Tissue Doppler and Hemodynamic Sample Placement 5.2 Ultrasound-Enhancing Agents and LV Opacification 5.3 Agitated-Saline Studies and Intracardiac Shunts
6 Chapter 6: Stress Echocardiography
6.1 Exercise Stress Echo Protocols and Peak Imaging 6.2 Pharmacologic Stress Echo, Dobutamine, and Safety 6.3 Non-Ischemic Stress Echo and Hemodynamic Provocation
7 Chapter 7: TEE, Strain, and 3-D TEE
7.1 Assisting TEE: Preparation, Probe Safety, Views, and Complications 7.2 Strain Acquisition, Tracking Quality, and Reproducibility 7.3 3-D TEE Acquisition, Cropping, Orientation, and Artifacts
8 Chapter 8: 3-D TTE and the Aortic Valve
8.1 3-D TTE Full-Volume Acquisition and Quantitation 8.2 Aortic-Valve Anatomy, Morphology, and Function 8.3 Aortic Stenosis: Velocities, Gradients, Valve Area, and Flow States
9 Chapter 9: Aortic Regurgitation and Mitral Structure
9.1 Aortic Regurgitation Mechanisms and Integrated Severity 9.2 Mitral-Valve Anatomy, Motion, and Mechanisms 9.3 Mitral Stenosis: Planimetry, Gradients, Pressure Half-Time, and Suitability
10 Chapter 10: Mitral and Tricuspid Valve Findings
10.1 Mitral Regurgitation Mechanism, Quantitation, and Severity Integration 10.2 Tricuspid-Valve Anatomy, Structure, and Function 10.3 Tricuspid Stenosis Assessment
11 Chapter 11: Right-Sided Valve Disease
11.1 Tricuspid Regurgitation Mechanism and Severity 11.2 Pulmonic-Valve Anatomy, Structure, and Function 11.3 Pulmonic Stenosis Assessment
12 Chapter 12: Pulmonic Regurgitation and Prosthetic Valves
12.1 Pulmonic Regurgitation Mechanism and Severity 12.2 Normal Mechanical and Bioprosthetic Valve Assessment 12.3 Prosthetic Obstruction, Regurgitation, Thrombosis, and Patient–Prosthesis Mismatch
13 Chapter 13: Endocarditis and Cardiac Chambers
13.1 Valvular Endocarditis, Vegetations, Abscess, and Complications 13.2 LV and LA Size, Geometry, Volumes, Mass, and Function 13.3 RV and RA Size, Pressure, Volume, and Function
14 Chapter 14: Cardiomyopathy Phenotypes and Diastology
14.1 Dilated and Hypertrophic Cardiomyopathies, SAM, and LVOT Obstruction 14.2 Restrictive, Arrhythmogenic, and Stress Cardiomyopathies 14.3 Diastolic Function, Filling Pressure, Grading, and Pitfalls
15 Chapter 15: Systolic Function and Ischemia
15.1 LV Systolic Function, Simpson EF, Regional Motion, and Output 15.2 RV Systolic Function: TAPSE, S-prime, FAC, and Coupling 15.3 Ischemic Heart Disease, Coronary Territories, Stress Response, and Complications
16 Chapter 16: Pericardium and Great Vessels
16.1 Pericardial Effusion, Tamponade, Constriction, and Doppler Physiology 16.2 Great Vessels, Venous Return, and Pulmonary Artery Assessment 16.3 Aortic Root, Aneurysm, Dissection, and Coarctation
17 Chapter 17: Pulmonary Pressure, Masses, and Congenital Recognition
17.1 Pulmonary Hypertension, RAP/PASP Estimation, and RV Consequences 17.2 Cardiac Masses, Thrombus, Tumor, Vegetation, and Mimics 17.3 Adult Recognition of ASD, VSD, PFO, PDA, and Congenital Clues
18 Chapter 18: Devices, Strain, and Hemodynamics
18.1 ICDs, Pacemakers, Occluders, Closure Devices, and Mechanical Support 18.2 Strain Interpretation, Global Longitudinal Strain, and Disease Patterns 18.3 Cardiac Hemodynamics, Bernoulli, Continuity, Stroke Volume, and Shunts
19 Chapter 19: Infiltrative Disease and Physics Foundations
19.1 Amyloid, Sarcoid, and Other Infiltrative Disease Patterns 19.2 Ultrasound Wave Properties, Propagation, Frequency, and Wavelength 19.3 Artifact Recognition: Reverberation, Shadowing, Mirror, Refraction, and Aliasing
20 Chapter 20: Resolution and Doppler Optimization
20.1 Axial/Lateral Resolution, Frame Rate, Depth, Focus, and Trade-Offs 20.2 Spectral Doppler Optimization, Nyquist, Filters, Gain, and Angle 20.3 Color Doppler Optimization, Scale, Priority, Variance, and Gain
21 Chapter 21: 2-D, 3-D, and Contrast Optimization
21.1 2-D Optimization: Frequency, Gain, TGC, Harmonics, Depth, and Focus 21.2 3-D Optimization: Volume Rate, Stitching, Cropping, and Display 21.3 Contrast Optimization: Mechanical Index, Destruction, Replenishment, and Artifacts
14.2 Restrictive, Arrhythmogenic, and Stress Cardiomyopathies
Key Takeaways Explain This Topic AI
Restrictive physiology describes rapid pressure rise in a stiff ventricle and is not itself an etiology; integrate ventricular morphology, biatrial remodeling, Doppler filling, tissue velocities, strain, and pericardial findings.
Arrhythmogenic cardiomyopathy can be right-dominant, biventricular, or left-dominant; an RV-focused study quantifies global and regional abnormalities, but diagnosis requires non-echo electrical, family, genetic, and tissue evidence.
Stress cardiomyopathy produces transient regional dysfunction that commonly extends beyond one coronary territory and may include LVOT obstruction, MR, RV involvement, thrombus, or shock.
Report a phenotype and urgent complications while preserving alternatives such as ischemia, myocarditis, pulmonary disease, athletic remodeling, congenital shunt, and constrictive pericarditis.
Last updated: July 2026
Restrictive physiology is not a single diagnosis
A restrictive cardiomyopathy (RCM) phenotype reflects stiff myocardium: ventricular diastolic pressure rises steeply with a small increase in volume. Ventricles may be normal or small with preserved EF early, while both atria enlarge, AV-valve regurgitation develops, pulmonary pressure rises, and systemic venous congestion appears. Advanced disease can reduce systolic function. Record mitral and tricuspid inflow, septal and lateral e′, E/e′ in its valid context, pulmonary and hepatic venous flow, LA and RA volumes, RV size/function, IVC, PASP, GLS, and pericardium. A short deceleration time, high E/A, short IVRT, and low annular e′ form a restrictive filling pattern but do not name its cause.
Wall thickness guides the differential without settling it. Amyloid can produce increased LV and RV wall thickness, small cavities, thickened valves and interatrial septum, biatrial enlargement, effusion, very low tissue velocities, and reduced GLS with relative apical sparing. Apical sparing is supportive, not diagnostic. Endomyocardial fibrosis or hypereosinophilic disease may cause apical obliteration, thrombus, and AV-valve tethering. Sarcoidosis, hemochromatosis, radiation, storage disease, and idiopathic RCM may look different or even dilated. Constrictive pericarditis can mimic restriction; marked respiratory inflow variation, septal shift, preserved or increased medial e′, and annulus reversus favor constriction, but an incomplete sign set should remain indeterminate.
Examine the arrhythmogenic phenotype systematically
Arrhythmogenic cardiomyopathy is not confined to a visibly enlarged RV. It can be right-dominant, biventricular, or left-dominant, and early disease may have a normal echocardiogram. Obtain a nonforeshortened RV-focused apical four-chamber view plus parasternal long-axis RV inflow, parasternal short-axis RVOT, and subcostal views. Measure RV basal and mid diameters, longitudinal length, RVOT in standardized planes, end-diastolic and end-systolic area, fractional area change, TAPSE, tissue Doppler S′, and RV free-wall strain when feasible. Three-dimensional RV volumes and EF add global assessment when image quality is adequate.
Look for regional akinesia, dyskinesia, aneurysm, systolic bulging, disproportionate RVOT enlargement, reduced global function, and RA dilation. Confirm any small bulge in orthogonal cine loops; near-field dropout, rib artifact, moderator band, tethering, pectus anatomy, and off-axis imaging create false regional abnormalities. Exclude pulmonary hypertension, important TR, shunt, RV infarction, myocarditis, congenital repair, and endurance-athlete remodeling. Do not diagnose arrhythmogenic cardiomyopathy from one RV dimension, one strain segment, or apparent fat. Current diagnosis integrates quantitative imaging with ventricular arrhythmia, ECG depolarization/repolarization, family history, genetics, and CMR tissue characterization.
Phenotype Echo pattern to seek Major mimic or required confirmation
Restrictive myocardial Biatrial enlargement, low e′, restrictive inflow, congestion Constrictive pericarditis and valve disease
Amyloid-like infiltrative Increased thickness, low GLS with relative apical sparing, effusion CMR, laboratory and nuclear/biopsy pathway
Arrhythmogenic Regional RV motion abnormality plus quantitative global change PH, shunt, athlete, RV infarct; ECG/genetic/CMR criteria
Stress cardiomyopathy Transient circumferential LV pattern beyond one artery Acute coronary syndrome and myocarditis
Recognize stress cardiomyopathy and its complications
Stress cardiomyopathy, often called Takotsubo syndrome, is an acute and usually reversible LV regional systolic phenotype. The classic pattern has apical and midventricular akinesia or dyskinesia with hyperdynamic basal segments, but midventricular, basal or reverse, and focal variants occur. Abnormality commonly crosses a single epicardial coronary distribution, which raises suspicion but does not exclude acute coronary occlusion. Clinical presentation, ECG, biomarkers, coronary evaluation, and often CMR are required to distinguish acute coronary syndrome and myocarditis.
Acquire all standard apical and short-axis levels, contrast unclear borders, and quantify EF without tracing thrombus as myocardium. Inspect the apex for spontaneous contrast or thrombus and assess RV involvement. Hyperdynamic basal contraction can produce SAM, posterior MR, and dynamic LVOT obstruction; use color and PW to localize, then record a separate CW gradient. Also look for low stroke volume, acute MR, pulmonary pressure elevation, pericardial effusion, and mechanical complications. Avoid inotropes or provocation decisions—the sonographer's role is accurate acquisition and immediate escalation of unstable findings.
Serial imaging is central: improvement or resolution supports a stress phenotype, while persistent regional dysfunction redirects the differential. Compare identical views and quantitative methods rather than relying on visual memory. Communicate apical thrombus, severe LVOTO, shock physiology, severe MR, suspected RV involvement, or new deterioration promptly.
Across all three groups, the final report should state the distribution of abnormal structure and motion; LV and RV volumes and function; atrial remodeling; diastolic and venous findings; GLS or RV strain quality; obstruction, valve disease, thrombus, and pressures; rhythm and loading conditions; prior-study change; and technical limitations. “Findings suggest a restrictive, arrhythmogenic, or stress phenotype” is more defensible than converting a suggestive echo sign into a final etiologic diagnosis.
Verify physiology and measurement quality
Restrictive inflow may be absent early or altered by diuretics, tachycardia, AF, MR, and changing preload. Sample both AV valves and systemic and pulmonary venous flow across visible respiration; discordant left- and right-sided findings should trigger review of rhythm, gain, sweep speed, and beat selection before labeling restriction.
Optimize an arrhythmogenic survey with an RV-focused view, adequate frame rate, stable ECG, complete free-wall strain tracking, and vendor-consistent analysis. A normal TAPSE cannot overrule convincing regional disease, while an abnormal TAPSE alone may reflect loading or translational motion. Combine longitudinal, area-based, deformation, and, when feasible, 3-D evidence. Repeat regional loops at a different depth and transducer position to test whether a suspected aneurysm follows myocardium or artifact.